You are here

generics

Biogen gets EU court ruling in favor of blocking Tecfidera generic entry

Biogen gets EU court ruling in favor of blocking Tecfidera generic entry

Seeking Alpha

multiple sclerosis

Flag link:

Jazz loses appeal, will have patent delisted from the Orange Book

Jazz loses appeal, will have patent delisted from the Orange Book

Endpoints

Flag link:

Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M

Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M

Endpoints

Flag link:

In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics

In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics

Fierce Pharma

Flag link:

Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication

Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication

Endpoints

product recalls

Flag link:

Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio

Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio

Endpoints

Flag link:

Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent

Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent

Endpoints

multiple sclerosis

Flag link:

Jazz sues generics makers for infringement on cannabis-derived epilepsy drug

Jazz sues generics makers for infringement on cannabis-derived epilepsy drug

Fierce Pharma

Flag link:

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Reuters

Flag link:

Mark Cuban’s Cost Plus Drug Company Continues To Revolutionize Generic Drug Pricing

Mark Cuban’s Cost Plus Drug Company Continues To Revolutionize Generic Drug Pricing

Forbes

Mark Cuban Cost Plus Drugs

Flag link:

Bags of shredded docs: Indian drugmaker Lupin handed a Form 483 by FDA inspectors

Bags of shredded docs: Indian drugmaker Lupin handed a Form 483 by FDA inspectors

Endpoints

Flag link:

FDA preps for DMD drug generics as Sarepta has yet to finish its confirmatory trial

FDA preps for DMD drug generics as Sarepta has yet to finish its confirmatory trial

Endpoints

Sarepta Therapeutics

Duchenne Muscular Dystrophy

Flag link:

'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says

'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says

Fierce Pharma

Bristol Myers Squibb

Flag link:

FDA sees room for growth for complex generics

FDA sees room for growth for complex generics

RAPS.org

complex generics

Flag link:

AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

Endpoints

Teva Pharmaceuticals

Flag link:

Even as Revlimid's star fades, Bristol Myers' core offerings have reached a 'critical mass,' CEO says

Even as Revlimid's star fades, Bristol Myers' core offerings have reached a 'critical mass,' CEO says

Fierce Pharma

Bristol Myers Squibb

Giovanni Caforio

Flag link:

Takeda sues Apotex over prospective generic versions of its top leukemia drug

Takeda sues Apotex over prospective generic versions of its top leukemia drug

Endpoints

Flag link:

Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug

Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug

CP WIre

Medicines Patent Pool

Flag link:

Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug

Medicines Patent Pool

Flag link:

Novartis' blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal

Novartis' blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal

Fierce Pharma

multiple sclerosis

Flag link:

Pages